PALI (Palisade Bio) Buyback Yield %: -0.89 (As of Jul. 03, 2026)


PALI Palisade Bio Inc PALI
35 GF Score
Price $2.11
! 2 Warning Signs
View Full Analysis

What is Palisade Bio Buyback Yield %?

Palisade Bio PALI +6.60% 35 Buyback Yield % is -0.89 as of Jul. 03, 2026. GuruFocus rates PALI with a GF Score™ of 35/100. The stock has 2 warning signs investors should review. Among 744 Biotechnology companies, Palisade Bio ranks better than 73.12% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Palisade Bio's current buyback yield was -0.89%.

Palisade Bio Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Palisade Bio's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Palisade Bio Buyback Yield % Chart

Palisade Bio Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Buyback Yield %
Get a 7-Day Free Trial -2.44 -46.62 -130.11 -172.18 -34.18

Palisade Bio Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 -34.18 -1.11

PALI vs IRD, GALT, VSTM: Buyback Yield % Comparison

For the Biotechnology subindustry, Palisade Bio's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Palisade Bio Buyback Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Palisade Bio's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Palisade Bio's Buyback Yield % falls into.


PALI
35GF Score
Palisade Bio Inc PALI
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Palisade Bio Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Palisade Bio's Buyback Yield for the fiscal year that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 128.219) / 375.1634
=-34.18%

Palisade Bio's annualized Buyback Yield for the quarter that ended in Mar. 2026 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 3.25) / 293.3385
=-1.11%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of -0.89 mean?
Palisade Bio (PALI) has a Buyback Yield % of -0.89 as of Jul. 03, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Palisade Bio and its competitors. According to the industry distribution chart, Palisade Bio ranks #200 out of 744 companies in the Biotechnology industry, placing it in the top 26.9%.
Is Palisade Bio's Buyback Yield % too high?
Palisade Bio's current Buyback Yield % is -0.89. Based on the distribution chart, Palisade Bio ranks #200 out of 744 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Palisade Bio has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does Palisade Bio's Buyback Yield % compare to IRD and GALT?
According to the Biotechnology industry distribution chart, Palisade Bio ranks #200 out of 744 companies for Buyback Yield %. This puts Palisade Bio in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Biotechnology company?
A good Buyback Yield % depends on the Biotechnology industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Palisade Bio and its competitors. Palisade Bio's current Buyback Yield % is -0.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Palisade Bio stock overvalued right now?
Palisade Bio (PALI) has a current Buyback Yield % of -0.89. The current Buyback Yield % is -0.89. Palisade Bio's overall GF Score™ is 35/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Palisade Bio (PALI), the current Buyback Yield % is -0.89 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Palisade Bio Business Description

Address 4600 South Syracuse Street, Suite 900, Denver, CO, USA, 80237
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
35GF Score

Get the complete analysis for PALI

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.11
Price